HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A Southwest Oncology Group Study.

Abstract
Nineteen patients considered to have metastatic primary extragonadal germ cell cancer were entered on a Phase II chemotherapy study using as induction therapy a combination of vinblastine (VLB) 12 mg/m2 day 1, bleomycin (BLEO) 15 U/m2 I.V. or I.M. twice weekly, and cis-diamminedichloroplatinum (DDP) 15 mg/m2 days 1-5, with vinblastine and DDP repeated at 28-day intervals for four months. All complete or partial responders were then placed on a maintenance regimen of vinblastine 12 mg/m2 alternating monthly with actinomycin-D 1.5 mg/m2 day 29, and chlorambucil, 10 mg/m2 P.O. days 32-37. There were three complete remissions (CR's), six partial remissions (PR's), and two stable disease. The response rate (CR's mpr's) was 56%; however the mean duration of response was only two months (range, 1-8 months). Drug toxicity was significant and there was one toxic death. Unlike patients with disseminated testicular cancer, patients with primary metastatic extragonadal germ cell carcinoma appear to do less well on this particular drug regimen. Further investigation using different drug regimens seems necessary.
AuthorsL G Feun, M K Samson, R L Stephens
JournalCancer (Cancer) Vol. 45 Issue 10 Pg. 2543-9 (May 15 1980) ISSN: 0008-543X [Print] United States
PMID6155194 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Bleomycin
  • Vinblastine
  • Cisplatin
Topics
  • Adult
  • Bleomycin (administration & dosage)
  • Cisplatin (administration & dosage)
  • Drug Evaluation
  • Drug Therapy, Combination
  • Dysgerminoma (drug therapy, radiotherapy)
  • Humans
  • Male
  • Mediastinal Neoplasms (drug therapy, radiotherapy)
  • Middle Aged
  • Neoplasm Metastasis
  • Retroperitoneal Neoplasms (drug therapy, radiotherapy)
  • Testicular Neoplasms (drug therapy, pathology)
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: